NeoGenomics, Inc. (NEO)
16.59
+0.20
(+1.22%)
USD |
NASDAQ |
Oct 23, 16:00
16.59
0.00 (0.00%)
After-Hours: 20:00
NeoGenomics Enterprise Value : 2.425B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.425B |
| October 22, 2026 | 2.399B |
| October 21, 2026 | 2.483B |
| October 20, 2026 | 2.429B |
| October 19, 2026 | 2.403B |
| October 16, 2026 | 2.433B |
| October 15, 2026 | 2.509B |
| October 14, 2026 | 2.462B |
| October 13, 2026 | 2.434B |
| October 12, 2026 | 2.375B |
| October 09, 2026 | 2.394B |
| October 08, 2026 | 2.352B |
| October 07, 2026 | 2.346B |
| October 06, 2026 | 2.414B |
| October 05, 2026 | 2.750B |
| October 02, 2026 | 2.665B |
| October 01, 2026 | 2.577B |
| September 30, 2026 | 2.651B |
| September 29, 2026 | 2.700B |
| September 28, 2026 | 2.770B |
| September 25, 2026 | 2.775B |
| September 24, 2026 | 2.805B |
| September 23, 2026 | 2.651B |
| September 22, 2026 | 2.719B |
| September 21, 2026 | 2.786B |
| Date | Value |
|---|---|
| September 18, 2026 | 2.850B |
| September 17, 2026 | 2.847B |
| September 16, 2026 | 2.726B |
| September 15, 2026 | 2.719B |
| September 14, 2026 | 2.658B |
| September 11, 2026 | 2.518B |
| September 10, 2026 | 2.555B |
| September 09, 2026 | 2.562B |
| September 08, 2026 | 2.549B |
| September 04, 2026 | 2.526B |
| September 03, 2026 | 2.536B |
| September 02, 2026 | 2.529B |
| September 01, 2026 | 2.535B |
| August 31, 2026 | 2.594B |
| August 28, 2026 | 2.612B |
| August 27, 2026 | 2.687B |
| August 26, 2026 | 2.525B |
| August 25, 2026 | 2.451B |
| August 24, 2026 | 2.402B |
| August 21, 2026 | 2.475B |
| August 20, 2026 | 2.417B |
| August 19, 2026 | 2.433B |
| August 18, 2026 | 2.337B |
| August 17, 2026 | 2.370B |
| August 14, 2026 | 2.342B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Quest Diagnostics, Inc. | 32.49B |
| Labcorp Holdings, Inc. | 33.25B |
| OPKO Health, Inc. | 1.313B |
| Psychemedics Corp. | -- |
| First Choice Healthcare Solutions, Inc. | 44.44M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.238M |
| Revenue (Quarterly) | 201.66M |
| Total Expenses (Quarterly) | 199.42M |
| EPS Diluted (Quarterly) | 0.0171 |
| Gross Profit Margin (Quarterly) | 44.06% |
| Profit Margin (Quarterly) | 1.11% |
| Earnings Yield | -2.43% |
| Normalized Earnings Yield | -2.312 |